Aquestive Therapeutics, Inc.: net_income
| Value | {"amount": -70539000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Aquestive Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:35:21.415897+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f57eb863-1c02-446e-8435-a916238279a3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-22-005393Retrieved: 2026-08-19T13:35:21.415897+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001398733/net-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f57eb863-1c02-446e-8435-a916238279a3
History
- no predecessors — first report